Literature DB >> 26597380

microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression.

Yongping Li1, Ruixue Huang2, Ling Wang1, Junsheng Hao1, Qiong Zhang3, Rui Ling1, Jun Yun1.   

Abstract

OBJECTIVES: miRNAs play crucial roles in human tumourigenesis. This study was performed to measure expression and function of miR-762 in breast cancer.
MATERIALS AND METHODS: Expression of miR-762 in breast tissues and cell lines (SK-BR-3, DA-MB-435s, MCF-7 and MDA-MB-231, HBL-100) was measured by using real-time RT-PCR. We restored expression of miR-762 in MCF-7 cells to measure its functional roles. Luciferase assays were performed to reveal the target gene of miR-762.
RESULTS: Expression of miR-762 was high in both breast cancer cell lines and specimens, and its overexpression increased breast cancer cell proliferation and invasion. Interferon regulatory factor 7 (IRF7) is a direct target of miR-762 and overexpression of miR-762 reduced expression of IRF7. Moreover, IRF7 was repressed, its levels inversely correlated to miR-762 expression. IRF7 rescued miR-762-induced cell invasion and proliferation.
CONCLUSIONS: These results demonstrate that miR-762 tumour effect was achieved by targeting IRF7 in human breast cancer specimens.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26597380      PMCID: PMC6496530          DOI: 10.1111/cpr.12223

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  32 in total

1.  Effects of targeted modulation of miR-762 on expression of the IFITM5 gene in Saos-2 cells.

Authors:  Xinkai Mo; Yanqin Lu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2014-02

Review 2.  miRNA in hepatocellular carcinoma.

Authors:  Asahiro Morishita; Tsutomu Masaki
Journal:  Hepatol Res       Date:  2014-08-06       Impact factor: 4.288

3.  MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells.

Authors:  H Ohdaira; M Sekiguchi; K Miyata; K Yoshida
Journal:  Cell Prolif       Date:  2011-12-13       Impact factor: 6.831

4.  Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.

Authors:  Chi-Hsiang Chiang; Ming-Feng Hou; Wen-Chun Hung
Journal:  Biochim Biophys Acta       Date:  2013-01-16

5.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

6.  The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma.

Authors:  Wen-Hui Zhang; Jun-Hao Gui; Chang-Zheng Wang; Qing Chang; Shi-Ping Xu; Chang-Hao Cai; Ying-Nan Li; Ya-Ping Tian; Li Yan; Benyan Wu
Journal:  Oncol Res       Date:  2012       Impact factor: 5.574

7.  MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro.

Authors:  Bojian Fei; Haorong Wu
Journal:  Oncol Res       Date:  2012       Impact factor: 5.574

8.  miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.

Authors:  Yee-Ming Lee; Jen-Yi Lee; Chao-Chi Ho; Qi-Sheng Hong; Sung-Liang Yu; Chii-Ruey Tzeng; Pan-Chyr Yang; Huei-Wen Chen
Journal:  Breast Cancer Res       Date:  2011-11-23       Impact factor: 6.466

9.  MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin.

Authors:  Zhiyu Wang; Neng Wang; Pengxi Liu; Qianjun Chen; Honglin Situ; Ting Xie; Jianxing Zhang; Cheng Peng; Yi Lin; Jianping Chen
Journal:  Oncotarget       Date:  2014-08-30

10.  MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.

Authors:  Ariel Bier; Nis Giladi; Noan Kronfeld; Hae Kyung Lee; Simona Cazacu; Susan Finniss; Cunli Xiang; Laila Poisson; Ana C deCarvalho; Shimon Slavin; Elad Jacoby; Michal Yalon; Amos Toren; Tom Mikkelsen; Chaya Brodie
Journal:  Oncotarget       Date:  2013-05
View more
  30 in total

1.  Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.

Authors:  Qiuming Yao; Xuan Wang; Weiwei He; Zhenyu Song; Bin Wang; Jinan Zhang; Qiu Qin
Journal:  Endocrine       Date:  2019-04-04       Impact factor: 3.633

2.  Construction and analysis of miRNA-mRNA regulatory networks in the radioresistance of nasopharyngeal carcinoma.

Authors:  Houyu Zhao; Aoshuang Chang; Junjun Ling; Wei Zhou; Huiping Ye; Xianlu Zhuo
Journal:  3 Biotech       Date:  2020-11-07       Impact factor: 2.406

3.  Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.

Authors:  Tomio Matsumura; Shigeaki Hida; Masato Kitazawa; Chifumi Fujii; Akira Kobayashi; Michiko Takeoka; Shun-Ichiro Taniguchi; Shin-Ichi Miyagawa
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

4.  MiR-762 regulates the activation of PI3K/AKT and Hippo pathways involved in the development of gastric cancer by targeting LZTS1.

Authors:  Kuaiyun Yu; Heng Zhu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

5.  Exosomes from human induced pluripotent stem cells-derived keratinocytes accelerate burn wound healing through miR-762 mediated promotion of keratinocytes and endothelial cells migration.

Authors:  Yunyao Bo; Lijun Yang; Baiting Liu; Guiping Tian; Chenxi Li; Lin Zhang; Yuan Yan
Journal:  J Nanobiotechnology       Date:  2022-06-21       Impact factor: 9.429

6.  The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.

Authors:  Peng-Hsu Chen; Chia-Hsiung Cheng; Chwen-Ming Shih; Kuo-Hao Ho; Cheng-Wei Lin; Chin-Cheng Lee; Ann-Jeng Liu; Cheng-Kuei Chang; Ku-Chung Chen
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

7.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

8.  Pharmacoepigenomics circuits induced by a novel retinoid-polyamine conjugate in human immortalized keratinocytes.

Authors:  Katerina Grafanaki; Ilias Skeparnias; Christos K Kontos; Dimitrios Anastasakis; Aigli Korfiati; George Kyriakopoulos; Konstantinos Theofilatos; Seferina Mavroudi; George Magoulas; Dionissios Papaioannou; Andreas Scorilas; Constantinos Stathopoulos; Denis Drainas
Journal:  Pharmacogenomics J       Date:  2021-06-18       Impact factor: 3.550

9.  A bioavailable cathepsin S nitrile inhibitor abrogates tumor development.

Authors:  Richard D A Wilkinson; Andrew Young; Roberta E Burden; Rich Williams; Christopher J Scott
Journal:  Mol Cancer       Date:  2016-04-21       Impact factor: 27.401

10.  MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1.

Authors:  Wei-Yang Tao; Chun-Yang Wang; Yong-Hui Sun; Yong-Hui Su; Da Pang; Guo-Qiang Zhang
Journal:  J Cancer       Date:  2016-07-25       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.